An ethopharmacological assessment of the effects of Zuclopenthixol on agonistic interactions in male mice

Methods and Findings in Experimental and Clinical Pharmacology

Volumn 21, Issue 1, 1999, Pages 11-15

  Manzaneque, J M ^b   Navarro, José Francisco ^a  

^a Campus de Teatinos   (Spain)

^b NONE

Author keywords

Aggression; Dopamine; Motor impairment; Neuroleptics; Zuclopenthixol

Indexed keywords

DOPAMINE RECEPTOR BLOCKING AGENT; NEUROLEPTIC AGENT; THIOXANTHENE DERIVATIVE; ZUCLOPENTHIXOL;

AGGRESSION; ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; CONTROLLED STUDY; DRUG EFFECT; DRUG MECHANISM; DRUG SCREENING; DRUG TOLERANCE; ETHNOPHARMACOLOGY; IMMOBILIZATION; MALE; MOTOR ACTIVITY; MOUSE; NONHUMAN; RECEPTOR BINDING;

EID: 0032914830     PISSN: 03790355     EISSN: None     Source Type: Journal    
DOI: 10.1358/mf.1999.21.1.527012     Document Type: Article

References (39)

1. Dollery, C., Boobis, A.R., Burley, D. Zuclopenthixol. In: Therapeutic Drugs. Churchill Livingstone: Edinburgh 1991, 209-14.
2. 1-mediated oral dyskinesia in rats. Life Sci 1986, 40: 223-5.
3. 2 antagonists. Pol J Pharmacol Pharm 1985, 36: 249-64.
4. Malt, U.F., Nystad, R., Bache, T., Noren, O., Sjaastad, M. Effectiveness of zuclopenthixol compared with haloperidol in the treatment of behavioural disturbances in learning disabled patients. Br J Psych 1995, 166: 374-7.
5. 2 receptor occupancy and effects of zuclopenthixol in humans. Int Clin Psychopharmacol 1995, 10: 221-7.
6. García Ribera, C. Nuevos antipsicóticos atípicos. Masson: Barcelona 1996.
7. Huttunen, M.O., Piepponen, T., Rantanen, H., Larmo, I., Nyholm, R., Raitasuo, V. Risperidone versus zuclopenthixol in the treatment of acute schizophrenic episodes: a double blind parallel-group trial. Acta Psychiat Scand 1995, 91: 271-7.
8. Laurier, C., Kennedy, W., Lachaine, J., Gariepy, L., Tessier, G. Economic evaluation of zuclopenthixol acetate compared with injectable haloperidol in schizophrenic patients with acute psychosis. Clin Ther 1997, 19: 316-29.
9. Carpenter, W.T., Wagman, A.M. Deficit and non deficit forms of schizophrenia: the concept. Am J Psychiatry 1988, 145: 578-80.
10. Heikkila, L., Eliander, H., Vartiainen, H., Turunen, M., Pedersen, V. Zuclopenthixol and haloperidol in patients with acute psychotic states. A double blind, multicentre studv. Curr Op Med Res 1992, 12: 594-603.
11. Romain, A., Dearmain, P., Gresi, E. et al. Efficacy of zuclopenthixol acetate on psychotic anxiety evaluated in an open study. Encephale 1996, 22: 280-6.
12. Nikulina, E.M., Klimek, V., Popova, N. K. Clopheline-induced aggression in mice: role of genotype and the dopaminergic system. Biull Eksp Biol Med 1989, 107: 47-9.
13. Singh, I., Owino, W.J.E. A double-blind comparison of zuclopenthixol tablets with placebo in the treatment of mentally handicapped in-patients with associated behavioral disorders. J Intel Dis Res 1992, 36: 541-9.
14. Coninck, G., Denis, A. The use of flupenthixol ('Fluanxol') in the management of behavioural disorders in disturbed and psychotic children. Pharmatherapeutica 1982, 3: 209-14.
15. Montgomery SA. The psychopharmacology of borderline personality disorders. Acta Psychiatr Belg 1987, 87: 260-6.
16. Brain, P.F., Benton, D., Childs, G., Parmigiani, S. The effect of the opponent in tests of murine aggression. Behav Processes 1981, 6: 319-28.
17. Valzelli, L. Aggressive behavior induced by isolation. In: Aggressive Behaviour. Gaffattini, S., Sigg, E.B. (Eds). Excerpta Medica: Amsterdam 1969, 70-6.
18. Navarro, J.F. An ethoexperimental analysis of the agonistic interactions in isolated male mice: comparison between OF.1 and NMRI strains. Psicothema 1997, 9: 333-6.
19. Brain, P.F., McAllister, K.H., Walmsley, S. Drug effects on social behavior: methods in ethopharmacology. In: Neuromethods. Boulton, A.A., Baker, G.B., Greenshaw, A.J. (Eds). Humana Press: New Jersey 1989, 687-739.
20. Martínez, M., Castaño, D., Simon, V., Brain, P.F. An ethopharmacological assessment of the influences of cyproterone acetate on social interactions in male mice. IRSC Med Sci 1986, 14: 44-5.
21. Bobon, D., Troisfontaine, B., Keempeneers, J.L. et al. Open multicentre trial of zuclopenthixol in mania and schizophrenia based on the AMDP scales. Acta Psychiat Belg 1986, 86: 152-76.
22. Lambert, P.A., Chabanes, J.P. Un noveau neuroleptique retard injectable à action sédative et antipìschotique: le decanoate de cis (Z)-clopenthixol. Encéphale 1984, 10: 83-91.
23. 1 receptor antagonists. Eur J Clin Pharmacol 1985, 28: 523-9.
24. Shintomi, K. Effects of psychotropic drugs on methamphetamine-induced behavioral excitation in grouped mice. Eur J Pharmacol 1975, 3 1: 195-206.
25. Maj, J., Rogut, Z., Skuza, G., Sowitska, H. Effects of chronic treatment with antidepressants on aggressiveness induced by clonidine in mice. J Neural Transm 1982, 55: 19-25.
26. Navarro, J.F., Miñarro, J., Simón, V.M. Antiaggressive and motor effects of haloperidol show different temporal patterns in the development of tolerance. Physiol Behav 1993, 53: 1055-9.
27. Manzaneque, J.M., Navarro, J.F. Tolerance to antiaggressive and motor activity of chlorpromazine after repeated administration to mice. Med Sci Res 1997, 25: 283-5.
28. Arregui, A., Azpiroz, A., Brain, P.F., Simón, V.M. Effects of two selective dopaminergic antagonists on ethologically-assessed encounters in male mice. Gen Pharmacol 1993, 24: 353-6.
29. Velasco, R., Navarro, J.F. Manzaneque, J.M., Cavas, M., Pedraza, C. Acute and subchronic effects of pimozide on isolation-induced aggression in male mice. Eur Neuropsychopharmacul 1998, 8(Suppl.): S239-40.
30. Martín-López, M., Caño, A., Navarro, J.F. Efectos de la administración de dosis altas de sulpiride sobre la conducta agonística en ratones machos. Psicothema 1996, 8: 161-6.
31. Navarro, J.M., Manzaneque, J.M., Martin-Lopez, M. Effects of three dopaminergic antagonists (haloperidol, tiapride, zuclopenthixol) on grooming behavior in male mice. Med Sci Res 1996, 24: 681-2.
32. 2 dopamine receptor occupancy during treatment with conventional and atypical neuroleptics. Psychopharmacology 1989, 99: S28-31.
33. Puigcerver, A., Navarro, J.F., Simón, V.M. Sorting out antiaggressive and motor effects of haloperidol by means of tolerance development. Med Sci Res 1996, 24: 343-5.
34. Navarro, J.F., Manzaneque, J.M. Acute and subchronic effects of tiapride on isolation-induced aggression in male-mice. Pharmacol Biochem Behav 1997, 58: 255-9.
35. Manzaneque, J.M., Navarro, J.F. Behavioral profile of amisulpride in agonistic encounters between male mice. Aggr Behav 1999, 25 (in press).
36. 2 antagonist, in tardive dyskinesia. Eur Neuropsychopharmacol 1991, 1: 541-8.
37. Navarro, J.F., Martín, J.M., Puigcerver, A., Lopez, E. Tolerance to cataleptic effects of haloperidol after repeated administration in male mice. Med Sci Res 1993, 21: 387-8.
38. Manzaneque, J.M., Arenas, M.C., Navarro, J.F. Tolerance to cataleptic effects of haloperidol after repeated administration in female mice. Med Sci Res 1995, 23: 549-50.
39. Christensen, A.V., Arnt, J., Svendsen, O. Animal models for neuroleptic induced dysfunction. In: Catecholamines: Neuropharmacology and Central Nervous System. Springer: Berlin 1984, 99-109.